M-DARUNAVIR

mantra pharma inc🇨🇦 Health Canada

Approval Id: 16e281e154ae9bc5
Drug Approval Canada Name: M-DARUNAVIR
Product Name: M-DARUNAVIR
Status: Cancelled Post Market
Status Date: 2023-06-20
Original Market Date: 2022-02-04
Din: 02522284
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 08:18.08.08
Atc Original: J05AE10 DARUNAVIR
Atc Name: j 05 ae 10
Aig Number: 0151656003
Company Name: mantra pharma inc
Company Address: 1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3

DARUNAVIR

600 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

16e281e154ae9bc5

Type

Standard